VANCOUVER, British Columbia, April 22, 2019 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces its wholly-owned subsidiary, CSPA Group, Inc., participated in the High Times 4/20 event at the Cal Expo in Sacramento, California, and Kushstock 4/20 event at the Adelanto Stadium in Adelanto, California.
CSPA Group had promotion booths set up at both events. Retailers who partnered with CSPA for these events sold out of the full inventory of CannaStrips™ before the conclusion of both.
Casey Fenwick, President of LDS, stated, "CannaStrips™ popularity continues to grow. I was personally present at the High Times 4/20 Sacramento event and the interest and acceptance of the CannaStrips™ product line was amazing, everyone wanted to know more about CannaStrips™ and details of the product line. There wasn't a moment that the booth didn't have multiple visitors. It was a great event for CSPA Group, CannaStrips™, and the Company in general."
LDS CEO, Brad Eckenweiler, stated, "Kushstock 4/20 event in Adelanto was very successful and the local retailer at the Saturday event sold out twice. CannaStrips™ continue to increase in popularity as more people have the opportunity to experience the discreet and effective delivery of cannabinoids in the CannaStrips™ product line."
The Company will continue to inform the market of corporate developments as they become available.
About CSPA Group, Inc.
CSPA Group, Inc. is located in Adelanto, California and is a City-Permitted and State-Licensed manufacturer and distributor/transporter in the California cannabis industry. CSPA Group manufactures extracted oils and distillates and produces CannaStrips™ under a license agreement with Lifestyle Delivery Systems Inc. a British Columbia corporation.
About Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.
Lifestyle Delivery Systems Inc. Brad Eckenweiler CEO & Director
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.